These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 15207541)

  • 41. Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles.
    Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
    J Microencapsul; 2009 Dec; 26(8):734-47. PubMed ID: 19888882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound.
    Silva AC; González-Mira E; García ML; Egea MA; Fonseca J; Silva R; Santos D; Souto EB; Ferreira D
    Colloids Surf B Biointerfaces; 2011 Aug; 86(1):158-65. PubMed ID: 21530187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.
    Dai W; Zhang D; Duan C; Jia L; Wang Y; Feng F; Zhang Q
    J Microencapsul; 2010 May; 27(3):234-41. PubMed ID: 20113167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
    Souto EB; Müller RH
    Handb Exp Pharmacol; 2010; (197):115-41. PubMed ID: 20217528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation and characterization of n-dodecyl-ferulate-loaded solid lipid nanoparticles (SLN).
    Souto EB; Anselmi C; Centini M; Müller RH
    Int J Pharm; 2005 May; 295(1-2):261-8. PubMed ID: 15848010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preservation of nanostructured lipid carriers (NLC).
    Obeidat WM; Schwabe K; Müller RH; Keck CM
    Eur J Pharm Biopharm; 2010 Sep; 76(1):56-67. PubMed ID: 20452422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel method to produce solid lipid nanoparticles using n-butanol as an additional co-surfactant according to the o/w microemulsion quenching technique.
    Mojahedian MM; Daneshamouz S; Samani SM; Zargaran A
    Chem Phys Lipids; 2013 Sep; 174():32-8. PubMed ID: 23743405
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity.
    Mendes AI; Silva AC; Catita JA; Cerqueira F; Gabriel C; Lopes CM
    Colloids Surf B Biointerfaces; 2013 Nov; 111():755-63. PubMed ID: 23954816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies.
    Ravani L; Esposito E; Bories C; Moal VL; Loiseau PM; Djabourov M; Cortesi R; Bouchemal K
    Int J Pharm; 2013 Oct; 454(2):695-702. PubMed ID: 23792467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbyl palmitate.
    Uner M; Wissing SA; Yener G; Müller RH
    Pharmazie; 2005 Aug; 60(8):577-82. PubMed ID: 16124399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine.
    Li Y; Dong L; Jia A; Chang X; Xue H
    Int J Biol Macromol; 2006 May; 38(3-5):296-9. PubMed ID: 16600362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.
    Liu J; Hu W; Chen H; Ni Q; Xu H; Yang X
    Int J Pharm; 2007 Jan; 328(2):191-5. PubMed ID: 16978810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles.
    Lippacher A; Müller RH; Mäder K
    Int J Pharm; 2001 Feb; 214(1-2):9-12. PubMed ID: 11282228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
    Hu L; Tang X; Cui F
    J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
    Attama AA; Müller-Goymann CC
    Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Solid lipid nanoparticles and nanostructured lipid carriers--innovative generations of solid lipid carriers.
    Shidhaye SS; Vaidya R; Sutar S; Patwardhan A; Kadam VJ
    Curr Drug Deliv; 2008 Oct; 5(4):324-31. PubMed ID: 18855604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.
    Garcês A; Amaral MH; Sousa Lobo JM; Silva AC
    Eur J Pharm Sci; 2018 Jan; 112():159-167. PubMed ID: 29183800
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipid nanoparticles for parenteral delivery of actives.
    Joshi MD; Müller RH
    Eur J Pharm Biopharm; 2009 Feb; 71(2):161-72. PubMed ID: 18824097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation.
    Müller RH; Runge SA; Ravelli V; Thünemann AF; Mehnert W; Souto EB
    Eur J Pharm Biopharm; 2008 Mar; 68(3):535-44. PubMed ID: 17804210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of surfactant properties on oxidative stability of beta-carotene encapsulated within solid lipid nanoparticles.
    Helgason T; Awad TS; Kristbergsson K; Decker EA; McClements DJ; Weiss J
    J Agric Food Chem; 2009 Sep; 57(17):8033-40. PubMed ID: 19691283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.